Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 3
1982 1
1983 5
1984 2
1985 3
1986 2
1987 3
1988 1
1989 2
1990 2
1991 4
1992 6
1993 10
1994 9
1995 8
1996 8
1997 8
1998 13
1999 17
2000 13
2001 24
2002 29
2003 44
2004 61
2005 70
2006 90
2007 104
2008 81
2009 112
2010 133
2011 137
2012 161
2013 189
2014 214
2015 239
2016 227
2017 241
2018 299
2019 331
2020 409
2021 405
2022 386
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

3,708 results
Results by year
Filters applied: . Clear all
Page 1
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA.
Wang Y, Meng X, Wang A, Xie X, Pan Y, Johnston SC, Li H, Bath PM, Dong Q, Xu A, Jing J, Lin J, Niu S, Wang Y, Zhao X, Li Z, Jiang Y, Li W, Liu L, Xu J, Chang L, Wang L, Zhuang X, Zhao J, Feng Y, Man H, Li G, Wang B; CHANCE-2 Investigators. Wang Y, et al. Among authors: xu a. N Engl J Med. 2021 Dec 30;385(27):2520-2530. doi: 10.1056/NEJMoa2111749. Epub 2021 Oct 28. N Engl J Med. 2021. PMID: 34708996 Clinical Trial.
Mapping the genetic landscape of DNA double-strand break repair.
Hussmann JA, Ling J, Ravisankar P, Yan J, Cirincione A, Xu A, Simpson D, Yang D, Bothmer A, Cotta-Ramusino C, Weissman JS, Adamson B. Hussmann JA, et al. Among authors: xu a. Cell. 2021 Oct 28;184(22):5653-5669.e25. doi: 10.1016/j.cell.2021.10.002. Epub 2021 Oct 20. Cell. 2021. PMID: 34672952 Free article.
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study.
Ren Z, Xu J, Bai Y, Xu A, Cang S, Du C, Li Q, Lu Y, Chen Y, Guo Y, Chen Z, Liu B, Jia W, Wu J, Wang J, Shao G, Zhang B, Shan Y, Meng Z, Wu J, Gu S, Yang W, Liu C, Shi X, Gao Z, Yin T, Cui J, Huang M, Xing B, Mao Y, Teng G, Qin Y, Wang J, Xia F, Yin G, Yang Y, Chen M, Wang Y, Zhou H, Fan J; ORIENT-32 study group. Ren Z, et al. Among authors: xu a. Lancet Oncol. 2021 Jul;22(7):977-990. doi: 10.1016/S1470-2045(21)00252-7. Epub 2021 Jun 15. Lancet Oncol. 2021. PMID: 34143971 Clinical Trial.
Reply.
Ma D, Liu X, Yang Y, Xu A. Ma D, et al. Among authors: xu a. J Hypertens. 2021 Aug 1;39(8):1728-1729. doi: 10.1097/HJH.0000000000002883. J Hypertens. 2021. PMID: 34188010 No abstract available.
Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning.
Koblan LW, Arbab M, Shen MW, Hussmann JA, Anzalone AV, Doman JL, Newby GA, Yang D, Mok B, Replogle JM, Xu A, Sisley TA, Weissman JS, Adamson B, Liu DR. Koblan LW, et al. Among authors: xu a. Nat Biotechnol. 2021 Nov;39(11):1414-1425. doi: 10.1038/s41587-021-00938-z. Epub 2021 Jun 28. Nat Biotechnol. 2021. PMID: 34183861 Free PMC article.
CircOGDH Is a Penumbra Biomarker and Therapeutic Target in Acute Ischemic Stroke.
Liu Y, Li Y, Zang J, Zhang T, Li Y, Tan Z, Ma D, Zhang T, Wang S, Zhang Y, Huang L, Wu Y, Su X, Weng Z, Deng D, Tsang CK, Xu A, Lu D. Liu Y, et al. Among authors: xu a. Circ Res. 2022 Mar 18;130(6):907-924. doi: 10.1161/CIRCRESAHA.121.319412. Epub 2022 Feb 22. Circ Res. 2022. PMID: 35189704
Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells.
Wu X, Shu L, Zhang Z, Li J, Zong J, Cheong LY, Ye D, Lam KSL, Song E, Wang C, Xu A, Hoo RLC. Wu X, et al. Among authors: xu a. Adv Sci (Weinh). 2021 Jun;8(11):e2003721. doi: 10.1002/advs.202003721. Epub 2021 Mar 27. Adv Sci (Weinh). 2021. PMID: 34105268 Free PMC article.
3,708 results